Fredrik Öberg

3PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 09, 2026
A phase Ib/2a study of fostrox in combination with lenvatinib as second line therapy in patients with advanced hepatocellular carcinoma.

|Jul 17, 2025
Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma.

Patrick Nylund, Berta Garrido-Zabala, Stefania Iliana Tziola

|Oct 29, 2024
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.

Ruth Plummer, Alastair Greystoke, Gregory Naylor

Pageof 1